Refresher course in melanoma surgery

Chairs:  R. Olofsson Bagge, SE - R. Audisio, SE

DESCRIPTION

The refresher course on melanoma surgery has been designed for surgical and medical oncologists with the aim to provide a comprehensive update concerning modern treatment for melanoma, as well as an overview of the latest advances in the field. Practical training will be offered in the frame of collegial discussions with participants and the faculty, a multidisciplinary conference, but also video presentations of common surgical techniques.

Attendance to the course is limited and by application only.

LEARNING OBJECTIVES

• Understand melanoma biology, epidemiology and pathology
• Update on treatment options for wide local excisions and basic flaps
• Update on sentinel node biopsy and lymph node dissections, including videos
• Learn about modern systemic targeted treatment and immunotherappy
• Learn about the role of adjuvant and neoadjuvant systemic treatment
• Learn about locoregional treatments including isolated limb perfusion, isolated limb infusion, electrochemotherapy and TVEC
• Learn about the role of surgery in metastatic disease
• Learn about the future development in the treatment of melanoma
• Debate controversies and challenges in melanoma care
• Improve practical skills in multidisciplinary management and follow-up of patients with melanoma

OFFICIAL LANGUAGE

The official language will be English. No translation will be available.

CME ACCREDITATION

The Refresher Course in Melanoma Surgery is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

It has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 10 European CME credits (ECMEC®s).

Each medical specialist should claim only those credits that he/she actually spent in the educational activity.

The EACCME® is an institution of the European Union of Medical Specialists (UEMS), www.uems.eu.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credits to AMA credits can be found here.

Live educational activities occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC® credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

ESCO - The ESO College

Being selected to take part in this ESO activity gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.
This event also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits.
Full and active participation in the event earns participants 9 ESCO credits.
Visit www.ESCO.org for more information on how to join ESCO.

PARTICIPATION

Attendance is limited to 30 participants and admittance is by competitive application only. Priority will be given to applicants who have attended an ESO masterclass.

Applicants should meet the following profile:

• Age between 30 and 45 years
• At least 2-3 years’ experience in oncology
• Fluency in English

Successful applicants are granted free registration.

Accommodation at for arrival on the 11^th October and departure on the 13^th October will be provided to participants not residing in the Dublin area.

ORGANISING SECRETARIAT

Corinne Hall
European School of Oncology (ESO)
Via Turati 29
IT- 20121 Milan

ph  +39 331 6125784
e-mail: chall@eso.net

Dolores Knupfer
European School of Oncology (ESO)
Via Vicenzo Vela 6
CH- 6500 Bellinzona

ph +41 91 820 09 52
e-mail: dknupfer@eso.net

Riccardo A. Audisio, Gothenburg University, Department of Surgery, Gothenburg, Sweden
John Crown, St Vincent's University Hospital, Dept of Medical Oncology, Dublin, IE
Ana Maria Forsea, Carol Davila University of Medicine and Pharmacy, Romanian Skin Cancer Foundation, Dept. of Dermatology, Bucharest, RO
Julie Gehl, University of Copenhagen, Department of Clinical Medicine, Copenhagen, DK
Dirk Grünhagen, Erasmus Medical Center, Oncology Department, Rotterdam, NL
Karolin Isaksson, Department of Surgery Kristianstad Hospital, Kristianstad, Sweden and Lund University, Lund, Sweden
Mark Lawler, Queens University Hospital, Centre for Cancer Research and Cell Biology, Belfast, UK
Alvin Lee, London, UK
Marc Moncrieff, Norfolk and Norwich University Hospital, Plastic ann reconstructive surgery, Norwich, UK
Roger Olofsson Bagge, Gothenburg University, Department of Surgery, Gothenburg, SE
Jens Rauch, University College Dublin, School of Biomolecular and Biomedical Science, Systems Biology, Dublin, IE
Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Dept. of Soft Tissue/Bone & Melanoma, Warszawa, PL
Anna Szumera-Cieckiewicz, National Cancer Institute, Department of Pathomorphology, Warsaw, PL
Winan Van Houdt, National Cancer Institute, Surgical Oncology Dept, Amsterdam, NL

Application deadline 16^th August 2024

Interested candidates should apply before 16th August online providing:

• Application template
• Motivation letter
• Short CV (template) with the list of publications (if the list of publication is not provided, it will be assumed that no articles have been published)

If you are a past ESO Masterclass participant, you only need to submit the application template.